Evidence map›Paper›PMID 28468931›Full record

ArticleOccupational and environmental medicine2017

Pleural abnormalities in the Framingham Heart Study: prevalence and CT image features.

Tetsuro Araki, Masahiro Yanagawa, Fangui Jenny Sun, Josée Dupuis, Mizuki Nishino, Yoshitake Yamada, George R Washko, David C Christiani, Noriyuki Tomiyama, George T O'Connor and 2 more

Abstract read
In one paragraph

Article in Occupational and environmental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Tetsuro ArakiDepartment of Radiology, Center for Pulmonary Functional Imaging, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0003-0440-6078
Masahiro YanagawaDepartment of Radiology, Osaka University Graduate School of Medicine, Suita, Japan.
Fangui Jenny SunDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
Josée DupuisDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
Mizuki NishinoDepartment of Radiology, Center for Pulmonary Functional Imaging, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Yoshitake YamadaDepartment of Radiology, Center for Pulmonary Functional Imaging, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
George R WashkoThe Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
David C ChristianiDepartment of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, USA.
Noriyuki TomiyamaDepartment of Radiology, Osaka University Graduate School of Medicine, Suita, Japan.
George T O'ConnorThe National Heart Lung and Blood Institute's Framingham Heart Study, Boston, Massachusetts, USA.
Gary M HunninghakeThe Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Hiroto HatabuDepartment of Radiology, Center for Pulmonary Functional Imaging, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Funding

Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SILVERMAN, EDWIN K · 2013 to 2025
$24.9M
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.R01HL111024 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HUNNINGHAKE, GARY MATTHEW · 2013 to 2022
$6.4M
The clinical impact of pulmonary vascular remodeling in smokersR01HL116473 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SAN JOSE ESTEPAR, RAUL, WASHKO, GEORGE R · 2013 to 2021
$5.0M
Skeletal muscle, subcutaneous fat, and clinical outcomes in smokersR01HL122464 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WASHKO, GEORGE R · 2015 to 2018
$2.1M
Computed Tomographic characterization of subjects enrolled in the STATCOPE trialR01HL107246 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WASHKO, GEORGE R · 2011 to 2014
$1.7M
CT Volume Measurement of Lung Cancer treated with Erlotinib: Genomic CorrelationK23CA157631 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI NISHINO, MIZUKI · 2011 to 2015
$902k
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
NCI NIH HHS K23 CA157631NHLBI NIH HHS N01 HC025195NHLBI NIH HHS P01 HL114501NHLBI NIH HHS R01 HL107246NHLBI NIH HHS R01 HL111024NHLBI NIH HHS R01 HL116473NHLBI NIH HHS R01 HL122464
6 · The paper itself

Abstract

backgroundThe prevalence of pleural abnormalities in the general population is an epidemiologically important index of asbestos exposure, which has not been investigated since a radiography-based study in 1980.

methodsWe examined 2633 chest CT scans (mean 59.2 years, 50% female) from the Framingham Heart Study (FHS) for the presence and image characteristics of pleural plaques and diffuse pleural thickening. Demographics and pulmonary function were stratified by the presence of pleural abnormalities in association with interstitial lung abnormalities.

resultsPleural abnormalities were present in 1.5% (95% CI 1.1% to 2.1%). Pleural lesions were most commonly bilateral (90.0%), multiple (77.5%), calcified (97.5%) and commonly involved posterior (lower: 92.5%, middle: 87.5%), anterior (upper: 77.5%, middle: 77.5%) and diaphragmatic areas (72.5%). Participants with pleural abnormalities were significantly older (75.7 years, p <0.0001), male (92.5%, p <0.0001), former or current smokers (80.0%, p <0.001) with higher pack-years (33.3, p <0.0001). No significant reduction was noted in pulmonary function measures (p=0.07-0.94) when adjusted for the associated covariates, likely due to small number of cases with pleural abnormalities. Information about prior history of asbestos exposure and occupation was not available.

conclusionsPleural plaques and diffuse pleural thickening are present on CT in 1.5% of the FHS cohort. The current prevalence of the pleural abnormalities is smaller than that reported in the previous population-based study using chest radiography, likely representing lower asbestos exposure in recent decades. The posterior portion of the pleura is most frequently involved but the anterior portion is also commonly involved.

Indexed as

AdultAgedAged, 80 and overAsbestosEnvironmental ExposureFemaleHumansLungMaleMiddle AgedPleuraPleural DiseasesPrevalenceRadiography, ThoracicTomography, X-Ray ComputedAsbestosasbestosCTdiffuse pleural thickeningepidemiologypleural plaque

Identifiers

PMID28468931
PMCPMC5701783

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.